A general insert label for peptide display on chimeric filamentous bacteriophages

Abstract

The foreign insert intended to be displayed via recombinant phage proteins can have a negative effect on protein expression and phage assembly. A typical example is the case of display of peptides longer than 6 amino acid residues on the major coat protein, protein VIII of the filamentous bacteriophages M13 and fd. A solution to this problem has been the use of "two-gene systems" generating chimeric phages that concomitantly express wild-type protein VIII along with recombinant protein VIII. Although the two-gene systems are much more permissive in regard to insert length and composition, some cases can still adversely affect phage assembly. Although these phages genotypically contain the desired DNA of the insert, they appear to be phenotypically wild type. To avoid false-negative results when using chimeric phages in binding studies, it is necessary to confirm that the observed lack of phage recognition is not due to faulty assembly and display of the intended insert. Here we describe a strategy for generating antibodies that specifically recognize recombinant protein VIII regardless of the nature of its foreign insert. These antibodies can be used as a general monitor of the display of recombinant protein VIII into phage particles.

Screening for novel peptides specifically binding to the surface of ectopic endometrium cells by phage display

“…Antibodies or polypeptide ligands with molecular affinity to the target can be easily and quickly selected for. However, the greatest advantage of phage display is its direct linkage between phage phenotype and its encapsulated genotype (16), which allows one to proceed without knowing the structural information of the target molecule in advance. Through DNA sequencing of positive phage clones enriched after several rounds of selection, one can indirectly deduce the exogenous peptides presented from the sequence of amino acids.…”

Efficient development and expression of scFv recombinant proteins against PD-L1 surface domain and potency in cancer therapy

“…Small peptide molecules may act a most vital source of the carrier due to high specificity, structure simplicity, easy manipulation and solid penetration ability to tumor cells (Bastien et al 2015). The most advantageous factor of phage display technology is that it recognizes the genotype and phenotypes binding and no need for its structural evidence in advance (Kaplan and Gershoni 2012;Silacci et al 2005). So, it is conceivable to acquire the amino acid sequence indirectly by the recombinant formation and sequence analysis of positive phages clones followed by screening procedure.…”

Identification of a peptide specifically targeting ovarian cancer by the screening of a phage display peptide library

“…Phage display technology is able to rapidly screen high-affinity antibodies or peptide ligands that bind with specific target molecules ( 11 ). The advantage of this technology is that it realizes the linkage between genotype and phenotype ( 12 ), and there is no need to know the structural information of the target molecule in advance ( 13 ). It is possible to obtain the amino acid sequence indirectly by sequencing the positive phage clones following a screening procedure.…”